MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease
- 26 March 2004
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 51 (4), 794-798
- https://doi.org/10.1002/mrm.20038
Abstract
The cerebral deposition of amyloid beta-peptide, a central event in Alzheimer's disease (AD) pathogenesis, begins several years before the onset of clinical symptoms. Noninvasive detection of AD pathology at this initial stage would facilitate intervention and enhance treatment success. In this study, high-field MRI was used to detect changes in regional brain MR relaxation times in three types of mice: 1). transgenic mice (PS/APP) carrying both mutant genes for amyloid precursor protein (APP) and presenilin (PS), which have high levels and clear accumulation of beta-amyloid in several brain regions, starting from 10 weeks of age; 2). transgenic mice (PS) carrying only a mutant gene for presenilin (PS), which show subtly elevated levels of Abeta-peptide without beta-amyloid deposition; and 3). nontransgenic (NTg) littermates as controls. The transverse relaxation time T(2), an intrinsic MR parameter thought to reflect impaired cell physiology, was significantly reduced in the hippocampus, cingulate, and retrosplenial cortex, but not the corpus callosum, of PS-APP mice compared to NTg. No differences in T(1) values or proton density were detected between any groups of mice. These results indicate that T(2) may be a sensitive marker of abnormalities in this transgenic mouse model of AD.Keywords
This publication has 20 references indexed in Scilit:
- Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 TransgenesExperimental Neurology, 2001
- Apparent diffusion coefficient and MR relaxation during osmotic manipulation in isolated turtle cerebellumMagnetic Resonance in Medicine, 2000
- Graded Reduction of Cerebral Blood Flow in Rat as Detected by the Nuclear Magnetic Resonance Relaxation Time T2: A Theoretical and Experimental ApproachJournal of Cerebral Blood Flow & Metabolism, 2000
- Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 TransgenesNeurobiology of Disease, 1999
- Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer DiseaseArchives of Neurology, 1998
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996
- Stimulate: A GUI based fMRI analysis software packageNeuroImage, 1996
- Cerebral amyloid deposition and diffuse plaques in ``normal'' agingNeurology, 1996
- Accurate T1 determination from inversion recovery images: Application to human brain at 4 TeslaMagnetic Resonance in Medicine, 1994